For help on how to get the results you want, see our search tips.
328 results
Medicine
Shortages Remove Shortages filter
Withdrawn applications Remove Withdrawn applications filter
Categories
Human Remove Human filter
-
List item
Withdrawn application: Ilaris
canakinumab, date of withdrawal: 26/10/2022, Post-authorisation, Last updated: 23/02/2023 -
List item
Withdrawn application: Aliqopa
copanlisib, date of withdrawal: 20/12/2021, Initial authorisation, Last updated: 10/02/2023 -
List item
Withdrawn application: Miplyffa
arimoclomol, date of withdrawal: 22/03/2022, Initial authorisation, Last updated: 08/02/2023 -
List item
Withdrawn application: Imbarkyd
bardoxolone methyl, date of withdrawal: 09/11/2022, Initial authorisation, Last updated: 07/02/2023 -
List item
Withdrawn application: Gavreto
pralsetinib, date of withdrawal: 03/11/2022, Post-authorisation, Last updated: 02/02/2023 -
List item
Withdrawn application: Olumiant
baricitinib, date of withdrawal: 07/12/2022, Post-authorisation, Last updated: 02/02/2023 -
List item
Withdrawn application: Febseltiq
infigratinib, date of withdrawal: 11/10/2022, Initial authorisation, Last updated: 30/01/2023 -
List item
Withdrawn application: Hervelous
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022 -
List item
Withdrawn application: Tuznue
trastuzumab, date of withdrawal: 14/09/2022, Initial authorisation, Last updated: 13/12/2022 -
List item
Withdrawn application: Exkivity
mobocertinib, date of withdrawal: 20/07/2022, Initial authorisation, Last updated: 24/11/2022 -
List item
Withdrawn application: Abylqis
arachis hypogaea extract, date of withdrawal: 17/12/2021, Initial authorisation, Last updated: 23/11/2022 -
List item
Withdrawn application: Sevsury
surufatinib, date of withdrawal: 01/08/2022, Initial authorisation, Last updated: 16/11/2022 -
List item
Withdrawn application: Parsaclisib Incyte Biosciences Distribution B.V.
parsaclisib, date of withdrawal: 27/06/2022, Initial authorisation, Last updated: 08/11/2022 -
List item
Withdrawn application: Dimherity
dimethyl fumarate, date of withdrawal: 22/02/2022, Initial authorisation, Last updated: 03/11/2022 -
List item
Withdrawn application: Imcivree
setmelanotide, date of withdrawal: 22/04/2022, Post-authorisation, Last updated: 28/09/2022 -
List item
Withdrawn application: HemAryo
eptacog alfa (activated), date of withdrawal: 06/05/2022, Initial authorisation, Last updated: 27/09/2022 -
List item
Withdrawn application: Aduhelm
aducanumab, date of withdrawal: 20/04/2022, Initial authorisation, Last updated: 01/08/2022 -
List item
Withdrawn application: Sitoiganap
autologous glioma tumor cell lysates (inactivated), allogeneic glioma tumor cell lysates (inactivated), allogeneic glioma tumor cells (inactivated), autologous glioma tumor cells (inactivated), date of withdrawal: 02/05/2022, Initial authorisation, Last updated: 17/06/2022 -
List item
Withdrawn application: Neffy
epinephrine, date of withdrawal: 04/04/2022, Initial authorisation, Last updated: 20/05/2022 -
List item
Withdrawn application: Zektayos - Hepjuvo
obeticholic acid, date of withdrawal: 09/12/2021, Initial authorisation, Last updated: 08/04/2022 -
List item
Withdrawn application: Brilique
ticagrelor, date of withdrawal: 15/12/2021, Post-authorisation, Last updated: 01/04/2022 -
List item
Withdrawn application: Cervarix
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), date of withdrawal: 22/10/2021, Post-authorisation, Last updated: 10/01/2022 -
List item
Withdrawn application: Livmarli
maralixibat, date of withdrawal: 23/08/2021, Initial authorisation, Last updated: 17/12/2021 -
List item
Withdrawn application: Flynpovi
eflornithine, sulindac, date of withdrawal: 12/10/2021, Initial authorisation, Last updated: 07/12/2021 -
List item
Withdrawn application: Zynyz
retifanlimab, date of withdrawal: 14/10/2021, Initial authorisation, Last updated: 29/11/2021